Konsume
Interval Day Week Month
Newswire Search Past 90 Days 13 stories 6 Publishers
Trending Today
Sort By: Snapshot
Buzz
Media Coverage
World View

Related Topics
Topic # Mentions Topic Reach
innovent6-
pfizer5-
lilly3-
verzenios3-
Prominent Journalists
Byline Articles Written Avg Reach
By Salong Debbarma 3 -
by PR Newswire 2 -
RTTNews Staff Writer 2 -
Frank Vinluan 2 -
by PR Newswire 1 -
By Bloomberg 1 -
TajSabreen Ahamed 1 -
Staff Writer 1 -


Innovent licenses IBI355 rights to Spero for up to $1.1bn

By Salong Debbarmapharmaceutical-business-review.com


After Antibiotic Approval, Spero Pivots to Immunology Aiming to Rival an Amgen Asset

Frank Vinluanmedcitynews.com


Innovent Grants Spero Ex-China Rights To Anti-CD40L Antibody IBI355 In Up To $1.1 Bln Deal

RTTNews Staff Writerrttnews.com


Eli Lilly and Innovent agree Verzenios commercialisation deal in China

By Salong Debbarmapharmaceutical-business-review.com


Innovent And Lilly Join Forces To Broaden Verzenios Reach In China

TajSabreen Ahamedrttnews.com


Innovent Biologics and Lilly Enter into Commercialization Agreement for Verzenios® (abemaciclib) in Mainland China

by PR Newswirethailand-business-news.com


Innovent Reports IBI343 Meets Primary Goal In Phase 3 G-HOPE-001 Trial In Gastric Cancer

RTTNews Staff Writerrttnews.com


Pfizer’s $10.5B Deal With One of China’s Top Cancer Biotechs Is Another Sign the Game is Changing

Frank Vinluanmedcitynews.com


Pfizer, Innovent Biologics sign $10.5bn cancer drug development deal

By Salong Debbarmapharmaceutical-business-review.com


China's Innovent Biologics signs drug deal with Pfizer worth up to $10.5bn

Staff Writerasia.nikkei.com

Execution: 0.12 Seconds. 47.5 mb used.